Moreover, our findings establish that WISP1 enhances metastatic plasticity in ER+ breast cancer by amplifying MIF signaling and engaging Lyn/Fyn-mediated cytoskeletal remodeling, even in low-CD74 contexts. The gene discussed is MIF; the disease is breast carcinoma.